Deletion of β-strand and α-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform

Journal of Virology

Volumn 75, Issue 21, 2001, Pages 10024-10032

  Vorberg, I ^a   Chan, K ^a   Priola, S A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MUTANT PROTEIN; PRION PROTEIN;

ALPHA HELIX; ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENE CONSTRUCT; GENE DELETION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SECONDARY STRUCTURE; PROTEIN TRANSPORT;

ANIMALS; ENDOPEPTIDASE K; MICE; MUTAGENESIS, SITE-DIRECTED; PRIONS; PROTEIN STRUCTURE, SECONDARY; TUMOR CELLS, CULTURED;

EID: 0034789531     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.21.10024-10032.2001     Document Type: Article

References (67)

1. Identification of a protein that purifies with the scrapie prion
2. Molecular location of a species specific epitope on the hamster scrapie agent protein
3. Evidence for synthesis of scrapie prion protein in the endocytic pathway
4. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells
5. Formation of protease-resistant prion protein in cell-free systems
6. Aggregates of scrapie associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state
7. Prion protein (PrP) biosynthesis in scrapie-infected and uninfected neuro-blastoma cells
8. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive
9. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells
10. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): Implications regarding the site of conversion of PrP to the protease-resistant state
11. Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies
12. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy
13. Foreign PrP expression and scrapie infection in tissue culture cell lines
14. A kinetic model for amyloid formation in the prion diseases: Importance of seeding
15. Chaperone-supervised conversion of prion protein to its protease-resistant form
16. Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): Cleavage of APP occurs in a late compartment of the default secretion pathway
17. Scrapie infectivity, fibrils and low molecular weight protein
18. Structure of the recombinant full-length hamster prion protein PrP(29-231): The N terminus is highly flexible
19. Prionics or the kinetic basis of prion diseases
20. Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection
21. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie
22. Heparin-like molecules bind differentially to prion proteins and change their intracellular metabolic-fate
23. Dynamic simulation of the mouse prion protein
24. Sc accumulation
25. The nature of the scrapie agent: The evolution of the virino
26. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease- resistant state
27. Interactions between heterologous forms of prion protein: Binding, inhibition of conversion, and species barriers
28. Scrapie prions: A three-dimensional model of an infectious fragment
29. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins
30. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease
31. Cell-free formation of protease-resistant prion protein
32. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro
33. Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells
34. NMR structure of the bovine prion protein
35. Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells
36. Separation and properties of cellular and scrapie prion protein
37. Signal transduction through prion protein
38. Recombinant scrapie-like prion protein of 106 amino acids is soluble
39. A cellular gene encodes scrapie PrP 27-30 protein
40. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion protein
41. Prion protein and species barriers in the transmissible spongiform encephalopathies
42. Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells
43. A single hamster amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells
44. Novel proteinaceous infectious particles cause scrapie
45. Molecular biology of prion diseases
46. Attempts to restore scrapie prion infectivity after exposure to protein denaturants
47. Purification and structural studies of a major scrapie prion protein
48. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication
49. Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: Role of prion protein expression in peripheral nerves and spleen
50. Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones
51. Characterization of scrapie infection in mouse neuroblastoma cells
52. Molecular assessment of the transmissibilities of BSE and scrapie to humans
53. NMR structure of the mouse prion protein domain PrP(121-231)
54. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-21)
55. Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells
56. Glycosylation differences between the normal and pathogenic prion protein isoforms
57. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein
58. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes
59. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing
60. Scrapie prion protein contains a phosphatidylinositol glycolipid
61. Prions and prion proteins
62. Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions
63. Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice
64. Synthesis and trafficking of prion proteins in cultured cells
65. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform
66. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein
67. NMR solution structure of human prion protein